Iofetamine

CHEMBL1201308 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

303.2 g/mol

LogP

3.6

Phase

4

This radioiodinated compound was developed for brain imaging using single-photon emission computed tomography (SPECT), as it crosses the blood-brain barrier and distributes in proportion to blood flow. It was used to evaluate cerebral blood flow in conditions like stroke and dementia.

분자량

303.1800 g/mol

LogP

3.60

TPSA

12.00 Å²

리핀스키 5의 법칙

통과

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)NC(C)Cc1ccc(I)cc1

InChI

InChI=1S/C12H18IN/c1-9(2)14-10(3)8-11-4-6-12(13)7-5-11/h4-7,9-10,14H,8H2,1-3H3

Molecular Formula

C12H18IN

HBD / HBA

1 / 1

회전 가능 결합

4

무거운 원자

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This radioiodinated compound was developed for brain imaging using single-photon emission computed tomography (SPECT), as it crosses the blood-brain barrier and distributes in proportion to blood flow. It was used to evaluate cerebral blood flow in conditions like stroke and dementia.

Yes, Iofetamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201308. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3729. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Iofetamine PillFYI에서

구조

핵심 데이터

분자식: C12H18IN

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.